Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1049849

Seroepidemiology of hepatitis E in patients on haemodialysis in Croatia


Mrzljak, Anna; Dinjar-Kujundzic, Petra; Knotek, Mladen; Kudumija, Boris; Ilic, Mario; Gulin, Marijana; Zibar, Lada; Hrstic, Irena; Jurekovic, Zeljka; Kolaric, Branko et al.
Seroepidemiology of hepatitis E in patients on haemodialysis in Croatia // International Urology and Nephrology, 52 (2020), 2; 371-378 doi:10.1007/s11255-019-02363-3 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1049849 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Seroepidemiology of hepatitis E in patients on haemodialysis in Croatia

Autori
Mrzljak, Anna ; Dinjar-Kujundzic, Petra ; Knotek, Mladen ; Kudumija, Boris ; Ilic, Mario ; Gulin, Marijana ; Zibar, Lada ; Hrstic, Irena ; Jurekovic, Zeljka ; Kolaric, Branko ; Jemersic, Lorena ; Prpic, Jelena ; Tomljenovic, Morana ; Vilibic-Cavlek, Tatjana

Izvornik
International Urology and Nephrology (0301-1623) 52 (2020), 2; 371-378

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Hepatitis E virus ; Seroprevalence ; Haemodialysis ; Risk factors

Sažetak
Purpose Data on the seroprevalence of hepatitis E virus (HEV) in heamodialysis (HD) patients are conflicting, ranging from 0 to 44%. The aim of this study was to determine the HEV seroprevalence and risk factors among HD patients in Croatia. Methods A total of 394 HD patients from six medical facilities in five Croatian cities (three sites in the continental and three sites in the coastal region) were tested for HEV IgM/IgG antibodies using an enzyme-linked immunosorbent assay. Additionally, all samples were tested for HEV RNA by RT-PCR. Sociodemographic data and risk factors were collected using a questionnaire. Results HEV IgG antibodies were detected in 110 (27.9%) patients. The seroprevalence varied significantly between dialysis centres, ranging from 5.2 to 43.4% (p = 0.001). HEV IgM antibodies were found in 0.04% of IgG positive patients. All patients tested negative for HEV RNA. Factors associated with HEV IgG seropositivity were age > 60 years (OR 8.17 ; 95% CI 1.08–62.14), living in the continental parts of the country (OR 2.58 ; 95% CI 1.55– 4.30), and transfusion of blood products (OR 1.66 ; 95% CI 1.01–2.73). After adjusting for age and gender, patients from continental regions had higher odds of HEV seropositivity compared to patients from coastal regions (OR 2.88 ; 95% CI 1.71–4.85) and those who had RBC transfusions (OR 1.70, 95% CI 1.02–2.69) compared to those who did not. Conclusion The study showed a high HEV seropositivity among HD patients in Croatia, with significant variations between geographical regions. Continental area of residence and RBC transfusion were the most significant risk factors for HEV seropositivity. Due to the high seroprevalence, routine HEV screening among HD patients, especially in transplant candidates should be considered.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita



POVEZANOST RADA


Ustanove:
Hrvatski zavod za javno zdravstvo,
Klinička bolnica "Merkur",
Hrvatski veterinarski institut, Zagreb,
Medicinski fakultet, Rijeka,
Medicinski fakultet, Zagreb,
Nastavni zavod za javno zdravstvo "Dr. Andrija Štampar",
Klinički bolnički centar Osijek,
Opća bolnica Pula,
Medicinski fakultet, Osijek,
Opća bolnica Dubrovnik

Citiraj ovu publikaciju

Mrzljak, Anna; Dinjar-Kujundzic, Petra; Knotek, Mladen; Kudumija, Boris; Ilic, Mario; Gulin, Marijana; Zibar, Lada; Hrstic, Irena; Jurekovic, Zeljka; Kolaric, Branko et al.
Seroepidemiology of hepatitis E in patients on haemodialysis in Croatia // International Urology and Nephrology, 52 (2020), 2; 371-378 doi:10.1007/s11255-019-02363-3 (međunarodna recenzija, članak, znanstveni)
Mrzljak, A., Dinjar-Kujundzic, P., Knotek, M., Kudumija, B., Ilic, M., Gulin, M., Zibar, L., Hrstic, I., Jurekovic, Z. & Kolaric, B. (2020) Seroepidemiology of hepatitis E in patients on haemodialysis in Croatia. International Urology and Nephrology, 52 (2), 371-378 doi:10.1007/s11255-019-02363-3.
@article{article, year = {2020}, pages = {371-378}, DOI = {10.1007/s11255-019-02363-3}, keywords = {Hepatitis E virus, Seroprevalence, Haemodialysis, Risk factors}, journal = {International Urology and Nephrology}, doi = {10.1007/s11255-019-02363-3}, volume = {52}, number = {2}, issn = {0301-1623}, title = {Seroepidemiology of hepatitis E in patients on haemodialysis in Croatia}, keyword = {Hepatitis E virus, Seroprevalence, Haemodialysis, Risk factors} }
@article{article, year = {2020}, pages = {371-378}, DOI = {10.1007/s11255-019-02363-3}, keywords = {Hepatitis E virus, Seroprevalence, Haemodialysis, Risk factors}, journal = {International Urology and Nephrology}, doi = {10.1007/s11255-019-02363-3}, volume = {52}, number = {2}, issn = {0301-1623}, title = {Seroepidemiology of hepatitis E in patients on haemodialysis in Croatia}, keyword = {Hepatitis E virus, Seroprevalence, Haemodialysis, Risk factors} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font